Check genetics to improve heart disease risk prediction
Part of Heart & circulation clinical trials.
This study looks at whether adding genetic information to a standard NHS Health Check can better predict a person’s risk of coronary artery disease (CAD). If you qualify, you may be asked to provide genetic information to help refine future risk estimates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can take part in an NHS Health Check
- You are between 40 and 74 years old
- You can understand the study and give permission (informed consent)
- You do not have a history of heart or blood-vessel disease (no prior cardiovascular disease)
- You do not have a blood-borne infection like HIV or hepatitis B
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new body markers (including possible genetic traits) to better predict who is likely to have future cardiovascular events. Your results could help doctors estimate risk and choose prevention strategies more accurately.
This trial looks at how learning about your genetic risk for heart disease might help prevent it. You will get a personalized report and guidance.
This trial uses a polygenic risk score to see if knowing your genetic risk for coronary artery disease can help prevent a first heart attack. If you have an intermediate 10-year risk and no prior heart events, you may be eligible.
This study looks at how to better sort people with heart disease into different risk groups. You may be asked for information about your heart condition and related health to help guide future care.
This study looks at factors that can predict health risks and uses non-invasive imaging (no major procedures) to collect information. It may help researchers better understand who is at higher risk over time and why.
This study follows people to understand heart disease risk by combining a heart risk score with genetic risk (polygenic risk). It may help improve how doctors identify who is at higher risk and could guide prevention planning.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.